Please enable JavaScript to continue using this application.

Compare $CNTB vs $RNXT | Chartloom

Compare

$CNTB vs $RNXT

Connect Biopharma Holdings Ltd · RenovoRx Inc

CNTB

Connect Biopharma Holdings Ltd

RNXT

RenovoRx Inc

Compare $CNTB vs $RNXT

Comparing Connect Biopharma Holdings Ltd and RenovoRx Inc

CNTBConnect Biopharma Holdings Ltd

RNXTRenovoRx Inc

CNTBConnect Biopharma Holdings Ltd

Market cap

$48M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

5.55x

Rev growth (TTM)

—

YTD performance

-65.5%

52W performance

-52.2%

FCF yield

-125.1%

RNXTRenovoRx Inc

Market cap

$58M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

8.70x

Rev growth (TTM)

198.5%

YTD performance

53.3%

52W performance

5.8%

FCF yield

-20.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CNTB

RNXT

Detailed metrics comparison

CNTB

Connect Biopharma Holdings Ltd

RNXT

RenovoRx Inc

Market Cap

CNTB$48M

RNXT$58M

Enterprise Value

CNTB$21M

RNXT$48M

Price

CNTB$0.87

RNXT$1.28

P/E Ratio

CNTBN/A

RNXTN/A

P/S Ratio

CNTB16.42x

RNXT29.18x

EV/Sales

CNTB7.27x

RNXT24.39x

EV/EBITDA

CNTB0.00x

RNXT0.00x

P/B Ratio

CNTB2.17x

RNXT7.94x

P/FCF Ratio

CNTBN/A

RNXTN/A

EV/FCF

CNTB-0.35x

RNXT-4.04x

PEG Ratio

CNTBN/A

RNXTN/A

Forward P/E (NTM)

CNTBN/A

RNXTN/A

Forward P/S (NTM)

CNTB5.55x

RNXT8.70x

Revenue (TTM)

CNTB$3M

RNXT$2M

Revenue Growth (YoY)

CNTBN/A

RNXT198.5%

Forward Rev Growth

CNTB98.8%

RNXT195.2%

Gross Margin (TTM)

CNTB0.0%

RNXT84.4%

Operating Margin (TTM)

CNTB0.0%

RNXT0.0%

EBITDA Margin (TTM)

CNTB-2361.3%

RNXT-684.9%

Net Margin (TTM)

CNTB-2336.3%

RNXT-621.7%

FCF Margin (TTM)

CNTB-2053.3%

RNXT-604.1%

Net Income (TTM)

CNTB$-69M

RNXT$-12M

FCF (TTM)

CNTB$-61M

RNXT$-12M

EPS (TTM)

CNTB-$1.24

RNXT-$0.26

ROE (TTM)

CNTB-16541.0%

RNXT-14563.0%

ROA (TTM)

CNTB-12158.0%

RNXT-10984.0%

ROIC (TTM)

CNTB-16541.0%

RNXT-14563.0%

Cash

CNTB$27M

RNXT$9M

Debt

CNTB$0

RNXT$0

Net Cash/Debt

CNTB$27M

RNXT$9M

Current Ratio (TTM)

CNTB2.37x

RNXT5.74x

Quick Ratio (TTM)

CNTB2.11x

RNXT5.37x

Debt/Equity (TTM)

CNTB0.00x

RNXT0.00x

Debt/Assets (TTM)

CNTB0.0%

RNXT0.0%

Interest Coverage (TTM)

CNTBN/A

RNXTN/A

Net Debt/EBITDA (TTM)

CNTB0.00x

RNXT0.00x

Beta

CNTB-0.07

RNXT1.07

52W Performance

CNTB-52.2%

RNXT5.8%

YTD Performance

CNTB-65.5%

RNXT53.3%

% from 52W High

CNTB-77.2%

RNXT-50.6%

% from 52W Low

CNTB2.3%

RNXT82.7%

Asset Turnover (TTM)

CNTB0.05x

RNXT0.18x

FCF Yield (TTM)

CNTB-125.1%

RNXT-20.7%

Earnings Yield (TTM)

CNTB-142.3%

RNXT-21.3%

Dividend Yield (TTM)

CNTBN/A

RNXTN/A

Rule of 40

CNTB-2,053.3

RNXT-405.6

EV/GP/RG

CNTBN/A

RNXT0.12

Ticker research

View CNTB research View RNXT research

Metric	CNTB Connect Biopharma Holdings Ltd	RNXT RenovoRx Inc
Market & Valuation
Market Cap	$48M	$58M
Enterprise Value	$21M	$48M
Price	$0.87	$1.28
P/E Ratio	N/A	N/A
P/S Ratio	16.42x	29.18x
EV/Sales	7.27x	24.39x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.17x	7.94x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.35x	-4.04x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	5.55x	8.70x
Revenue & Growth
Revenue (TTM)	$3M	$2M
Revenue Growth (YoY)	N/A	198.5%
Forward Rev Growth	98.8%	195.2%
Profitability
Gross Margin (TTM)	0.0%	84.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-2361.3%	-684.9%
Net Margin (TTM)	-2336.3%	-621.7%
FCF Margin (TTM)	-2053.3%	-604.1%
Net Income (TTM)	$-69M	$-12M
FCF (TTM)	$-61M	$-12M
EPS (TTM)	-$1.24	-$0.26
ROE (TTM)	-16541.0%	-14563.0%
ROA (TTM)	-12158.0%	-10984.0%
ROIC (TTM)	-16541.0%	-14563.0%
Financial Health
Cash	$27M	$9M
Debt	$0	$0
Net Cash/Debt	$27M	$9M
Current Ratio (TTM)	2.37x	5.74x
Quick Ratio (TTM)	2.11x	5.37x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.07	1.07
52W Performance	-52.2%	5.8%
YTD Performance	-65.5%	53.3%
% from 52W High	-77.2%	-50.6%
% from 52W Low	2.3%	82.7%
Efficiency & Yields
Asset Turnover (TTM)	0.05x	0.18x
FCF Yield (TTM)	-125.1%	-20.7%
Earnings Yield (TTM)	-142.3%	-21.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-2,053.3	-405.6
EV/GP/RG	N/A	0.12
Ticker research	View CNTB research	View RNXT research

Valuation

P/S Ratio

CNTB

16.42x

RNXT

29.18x

EV/FCF

RNXT

-4.04x

CNTB

-0.35x

Growth & revenue

Revenue Growth TTM

RNXT

198.5%

Forward Revenue Growth

RNXT

195.2%

CNTB

98.8%

Profitability & performance

Gross Margin

RNXT

84.4%

CNTB

0.0%

ROE

RNXT

-14563.0%

CNTB

-16541.0%

FCF Yield %

RNXT

-20.7%

CNTB

-125.1%

52-Week Performance

RNXT

5.8%

CNTB

-52.2%

Detailed metrics comparison

CNTB

Connect Biopharma Holdings Ltd

RNXT

RenovoRx Inc

Market Cap

CNTB$48M

RNXT$58M

Enterprise Value

CNTB$21M

RNXT$48M

Price

CNTB$0.87

RNXT$1.28

P/E Ratio

CNTBN/A

RNXTN/A

P/S Ratio

CNTB16.42x

RNXT29.18x

EV/Sales

CNTB7.27x

RNXT24.39x

EV/EBITDA

CNTB0.00x

RNXT0.00x

P/B Ratio

CNTB2.17x

RNXT7.94x

P/FCF Ratio

CNTBN/A

RNXTN/A

EV/FCF

CNTB-0.35x

RNXT-4.04x

PEG Ratio

CNTBN/A

RNXTN/A

Forward P/E (NTM)

CNTBN/A

RNXTN/A

Forward P/S (NTM)

CNTB5.55x

RNXT8.70x

Revenue (TTM)

CNTB$3M

RNXT$2M

Revenue Growth (YoY)

CNTBN/A

RNXT198.5%

Forward Rev Growth

CNTB98.8%

RNXT195.2%

Gross Margin (TTM)

CNTB0.0%

RNXT84.4%

Operating Margin (TTM)

CNTB0.0%

RNXT0.0%

EBITDA Margin (TTM)

CNTB-2361.3%

RNXT-684.9%

Net Margin (TTM)

CNTB-2336.3%

RNXT-621.7%

FCF Margin (TTM)

CNTB-2053.3%

RNXT-604.1%

Net Income (TTM)

CNTB$-69M

RNXT$-12M

FCF (TTM)

CNTB$-61M

RNXT$-12M

EPS (TTM)

CNTB-$1.24

RNXT-$0.26

ROE (TTM)

CNTB-16541.0%

RNXT-14563.0%

ROA (TTM)

CNTB-12158.0%

RNXT-10984.0%

ROIC (TTM)

CNTB-16541.0%

RNXT-14563.0%

Cash

CNTB$27M

RNXT$9M

Debt

CNTB$0

RNXT$0

Net Cash/Debt

CNTB$27M

RNXT$9M

Current Ratio (TTM)

CNTB2.37x

RNXT5.74x

Quick Ratio (TTM)

CNTB2.11x

RNXT5.37x

Debt/Equity (TTM)

CNTB0.00x

RNXT0.00x

Debt/Assets (TTM)

CNTB0.0%

RNXT0.0%

Interest Coverage (TTM)

CNTBN/A

RNXTN/A

Net Debt/EBITDA (TTM)

CNTB0.00x

RNXT0.00x

Beta

CNTB-0.07

RNXT1.07

52W Performance

CNTB-52.2%

RNXT5.8%

YTD Performance

CNTB-65.5%

RNXT53.3%

% from 52W High

CNTB-77.2%

RNXT-50.6%

% from 52W Low

CNTB2.3%

RNXT82.7%

Asset Turnover (TTM)

CNTB0.05x

RNXT0.18x

FCF Yield (TTM)

CNTB-125.1%

RNXT-20.7%

Earnings Yield (TTM)

CNTB-142.3%

RNXT-21.3%

Dividend Yield (TTM)

CNTBN/A

RNXTN/A

Rule of 40

CNTB-2,053.3

RNXT-405.6

EV/GP/RG

CNTBN/A

RNXT0.12

Ticker research

View CNTB research View RNXT research

Metric	CNTB Connect Biopharma Holdings Ltd	RNXT RenovoRx Inc
Market & Valuation
Market Cap	$48M	$58M
Enterprise Value	$21M	$48M
Price	$0.87	$1.28
P/E Ratio	N/A	N/A
P/S Ratio	16.42x	29.18x
EV/Sales	7.27x	24.39x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.17x	7.94x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.35x	-4.04x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	5.55x	8.70x
Revenue & Growth
Revenue (TTM)	$3M	$2M
Revenue Growth (YoY)	N/A	198.5%
Forward Rev Growth	98.8%	195.2%
Profitability
Gross Margin (TTM)	0.0%	84.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-2361.3%	-684.9%
Net Margin (TTM)	-2336.3%	-621.7%
FCF Margin (TTM)	-2053.3%	-604.1%
Net Income (TTM)	$-69M	$-12M
FCF (TTM)	$-61M	$-12M
EPS (TTM)	-$1.24	-$0.26
ROE (TTM)	-16541.0%	-14563.0%
ROA (TTM)	-12158.0%	-10984.0%
ROIC (TTM)	-16541.0%	-14563.0%
Financial Health
Cash	$27M	$9M
Debt	$0	$0
Net Cash/Debt	$27M	$9M
Current Ratio (TTM)	2.37x	5.74x
Quick Ratio (TTM)	2.11x	5.37x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.07	1.07
52W Performance	-52.2%	5.8%
YTD Performance	-65.5%	53.3%
% from 52W High	-77.2%	-50.6%
% from 52W Low	2.3%	82.7%
Efficiency & Yields
Asset Turnover (TTM)	0.05x	0.18x
FCF Yield (TTM)	-125.1%	-20.7%
Earnings Yield (TTM)	-142.3%	-21.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-2,053.3	-405.6
EV/GP/RG	N/A	0.12
Ticker research	View CNTB research	View RNXT research